| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 277 | 14.650 | 28.372 | 35.251 | 54.335 | 46.374 | 36.884 | 36.648 | 40.237 |
| Total Income - EUR | - | 277 | 14.641 | 28.616 | 35.860 | 54.700 | 47.136 | 37.622 | 37.100 | 40.351 |
| Total Expenses - EUR | - | 89 | 57 | 358 | 358 | 6.886 | 8.636 | 11.095 | 17.199 | 18.336 |
| Gross Profit/Loss - EUR | - | 187 | 14.584 | 28.259 | 35.502 | 47.814 | 38.500 | 26.527 | 19.901 | 22.016 |
| Net Profit/Loss - EUR | - | 179 | 14.145 | 27.407 | 34.445 | 46.295 | 37.137 | 25.572 | 19.589 | 21.621 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Advanced Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 128 | 126 | 0 | 0 | 25.854 | 19.557 | 13.876 | 8.109 | 2.425 |
| Current Assets | - | 327 | 14.809 | 29.273 | 35.129 | 39.360 | 51.016 | 29.441 | 43.113 | 55.428 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 2.738 | 14.439 | 10.585 | 2.330 | 2.572 | 3.489 | 12.619 |
| Cash | - | 327 | 14.809 | 26.536 | 20.690 | 28.776 | 48.686 | 26.870 | 39.624 | 42.809 |
| Shareholders Funds | - | 224 | 14.365 | 27.450 | 34.487 | 50.980 | 59.323 | 25.621 | 45.133 | 55.576 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 231 | 570 | 1.823 | 643 | 14.382 | 11.579 | 17.717 | 6.108 | 2.379 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Advanced Clinical Research Srl